Skip to content
    Mass General Brigham Ventures logo

    Mass General Brigham Ventures

    Boston, Massachusetts, United StatesFounded 2008

    Mass General Brigham Ventures is an early-stage venture capital firm that invests in life science companies, including digital health, medical devices, diagnostics, and drugs, which emerge from the Mass General Brigham health system's research community. Their strategy involves leveraging this proprietary deal flow and providing strategic support for long-term value creation, primarily at the seed and Series A stages, to develop transformative solutions for unmet medical needs.

    83% of their portfolio is in Healthcare. Average disclosed round size is $38.0M (across 6 rounds with reported amounts).

    Find people at Mass General Brigham Ventures on Goldilocks AI

    Portfolio

    6

    Fund Size

    $450M

    Top Stage

    Seed

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    6 investments
    CompanyRoundAmountDate
    Carta Healthcare logoCarta HealthcareSeries B$18.3MMay 2025
    TTuesday HealthSeries C$60MMay 2024
    Claris Bio logoClaris BioSeries A$57MJan 2024
    VViolet TherapeuticsSeed$10.6MMay 2023
    Rippl logoRipplSeed$32MSep 2022
    DexCare logoDexCareSeries B$50MJan 2022

    Top Co-Investors

    Ono Venture Investment1 shared
    Valtruis1 shared
    Janus Henderson Investors1 shared
    Transformation Capital1 shared
    Providence Ventures1 shared
    UPMC Enterprises1 shared
    MemorialCare Innovation Fund1 shared
    Memorial Hermann Health System1 shared
    CU Healthcare Innovation Fund1 shared

    Last updated: 8 March 2026